Difficulty: Medium
Average Score: 81%
Practice
All of the following statements regarding inhibitors of type III phosphodiesterase are true EXCEPT:
Correct answer
C
Rationale
The correct answer is C. Type III phosphodiesterase inhibitors increase cAMP levels in cardiac myocytes, leading to positive inotropic and vasodilatory effects, reducing afterload. They are associated with the risk of cardiac arrhythmias due to their effects on cardiac contractility. However, they do not show significant cross-tolerance with beta-receptor agonists, as they act via a different mechanism. Therefore, choice C is incorrect.